Variant report

Variant	nsv549792
Chromosome Location	chr10:1591836-1610839
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:4)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:1608518..1611071-chr10:1611405..1613582,2	MCF-7	breast:
2	chr10:1609725..1612525-chr10:1613724..1616167,2	MCF-7	breast:
3	chr10:1592945..1595244-chr10:1605533..1608075,2	K562	blood:
4	chr10:1592945..1595244-chr10:1605533..1608075,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-WDR37-2	chr10:1598806-1599179	NONHSAT010932
2	lnc-WDR37-2	chr10:1598806-1599680	NONHSAT010934
3	lnc-WDR37-2	chr10:1598806-1599179	ENSG00000205696.4
4	lnc-WDR37-2	chr10:1598806-1599680	NONHSAT010935

No data

Extended variants
information (count: 1019 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:1019 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10903478	chr10:1591836-1591837	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs545813713	chr10:1591847-1591848	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs368843606	chr10:1591850-1591851	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs140628372	chr10:1591865-1591866	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs10903479	chr10:1591881-1591882	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs11250614	chr10:1591901-1591902	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs561707000	chr10:1591920-1591921	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs367810916	chr10:1591921-1591922	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs113511346	chr10:1591927-1591928	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs371559408	chr10:1591930-1591931	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs547411266	chr10:1591940-1591941	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs7895066	chr10:1591960-1591961	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs180708290	chr10:1591961-1591962	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs11250615	chr10:1591971-1591972	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs186336839	chr10:1591975-1591976	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs145784633	chr10:1591986-1591987	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs543600049	chr10:1591990-1591991	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs555166500	chr10:1591994-1591995	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs576696918	chr10:1591999-1592000	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs568588966	chr10:1592015-1592016	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs4880864	chr10:1592023-1592024	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs554207976	chr10:1592030-1592031	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs190787425	chr10:1592037-1592038	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs545825477	chr10:1592038-1592039	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs556161564	chr10:1592054-1592055	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs576227122	chr10:1592061-1592062	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs541591365	chr10:1592075-1592076	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs78790863	chr10:1592081-1592082	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs527536217	chr10:1592086-1592087	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs541220384	chr10:1592126-1592127	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs12243972	chr10:1592136-1592137	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs564041074	chr10:1592152-1592153	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs562030308	chr10:1592194-1592195	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs369592405	chr10:1592272-1592273	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs552167394	chr10:1592289-1592290	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs568883116	chr10:1592319-1592320	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs4880865	chr10:1592327-1592328	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs113078636	chr10:1592360-1592361	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs548427001	chr10:1592361-1592362	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs568531770	chr10:1592374-1592375	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs375816749	chr10:1592387-1592388	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs534133178	chr10:1592396-1592397	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs4880866	chr10:1592399-1592400	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs11250616	chr10:1592406-1592407	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs74624419	chr10:1592437-1592438	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs150273518	chr10:1592451-1592452	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs2813354	chr10:1592517-1592518	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs369021464	chr10:1592563-1592564	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs555219521	chr10:1592602-1592603	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs572058230	chr10:1592668-1592669	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Breast cancer	20409316	CNVD
Gastric adenocarcinoma	19115996	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Breast cancer	17133270	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Cancer	21129771	CNVD
Sudden cardiac death	19188705	CNVD
Digeorge syndrome	22283845	CNVD
Colorectal cancer	20709793	CNVD
Wilms tumour	19047088	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Barakat syndrome	22470819	CNVD
Melanoma	18172304	CNVD
Ovarian cancer	21720365	CNVD
Autism	18414403	CNVD
Malignant melanoma	18718029	CNVD
Breast cancer	22032731	CNVD
Medulloblastoma	16783165	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Melanoma	17363583	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	21509527	CNVD
Prostate cancer	18632612	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Autism	22543975	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:81 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:1585200-1594800	Weak transcription	Right Atrium	heart
2	chr10:1588800-1592000	Weak transcription	Fetal Thymus	thymus
3	chr10:1589200-1593800	Weak transcription	Brain Germinal Matrix	brain
4	chr10:1589800-1594200	Weak transcription	Brain Substantia Nigra	brain
5	chr10:1590800-1592600	Enhancers	Dnd41	blood
6	chr10:1591800-1592200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr10:1592000-1594600	Enhancers	Fetal Thymus	thymus
8	chr10:1592200-1594000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr10:1592400-1592600	Enhancers	Fetal Heart	heart
10	chr10:1592400-1594600	Weak transcription	Fetal Brain Male	brain
11	chr10:1592600-1592800	Enhancers	Fetal Lung	lung
12	chr10:1592600-1593400	Flanking Active TSS	Dnd41	blood
13	chr10:1592600-1593800	Weak transcription	Fetal Heart	heart
14	chr10:1593400-1595400	Enhancers	Fetal Muscle Leg	muscle
15	chr10:1593400-1595400	Enhancers	Dnd41	blood
16	chr10:1593600-1594400	Enhancers	Fetal Muscle Trunk	muscle
17	chr10:1593800-1596400	Enhancers	Brain Germinal Matrix	brain
18	chr10:1593800-1596600	Enhancers	Fetal Heart	heart
19	chr10:1594000-1594800	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr10:1594200-1594400	Enhancers	Brain Substantia Nigra	brain
21	chr10:1594400-1594800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr10:1594400-1594800	Weak transcription	Brain Substantia Nigra	brain
23	chr10:1594400-1594800	Enhancers	Right Ventricle	heart
24	chr10:1594400-1596000	Enhancers	Fetal Brain Female	brain
25	chr10:1594400-1596600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
26	chr10:1594600-1595600	Enhancers	Fetal Lung	lung
27	chr10:1594600-1596200	Enhancers	Fetal Brain Male	brain
28	chr10:1594600-1601400	Weak transcription	Fetal Thymus	thymus
29	chr10:1594800-1595000	Enhancers	Right Atrium	heart
30	chr10:1594800-1595200	Enhancers	Brain Substantia Nigra	brain
31	chr10:1594800-1604200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
32	chr10:1594800-1604800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr10:1595000-1601600	Weak transcription	Right Atrium	heart
34	chr10:1595400-1596800	Bivalent Enhancer	Fetal Muscle Leg	muscle
35	chr10:1595400-1609200	Weak transcription	Dnd41	blood
36	chr10:1596200-1598000	Weak transcription	Fetal Brain Male	brain
37	chr10:1598200-1598400	Enhancers	Fetal Brain Male	brain
38	chr10:1600400-1601600	Weak transcription	Spleen	Spleen
39	chr10:1600800-1602400	Bivalent Enhancer	Fetal Stomach	stomach
40	chr10:1601000-1601200	Enhancers	Brain Cingulate Gyrus	brain
41	chr10:1601000-1601800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
42	chr10:1601000-1602400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
43	chr10:1601200-1601600	Enhancers	Brain Anterior Caudate	brain
44	chr10:1601200-1601600	Bivalent Enhancer	Brain Cingulate Gyrus	brain
45	chr10:1601200-1601800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
46	chr10:1601200-1603000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
47	chr10:1601200-1603000	Bivalent Enhancer	Fetal Lung	lung
48	chr10:1601400-1601600	Bivalent Enhancer	Fetal Heart	heart
49	chr10:1601400-1601800	Enhancers	Fetal Thymus	thymus
50	chr10:1601400-1602000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links